Dyadic International Inc (DYAI) stock
DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.32+0.00 (+1.30%)
Close on Nov 18, 2026Market cap $11.66MP/E –Yield –
Dyadic International operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Dyadic International's operating cash flow for the twelve months ending Sep 30, 2026 was -$7.04M. For fiscal 2025 it was -$5.70M. The highest annual figure on record is -$1.69M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.70M | – |
| FY2024 | Dec 31, 2024 | -$3.97M | – |
| FY2023 | Dec 31, 2023 | -$6.73M | – |
| FY2022 | Dec 31, 2022 | -$8.08M | – |
| FY2021 | Dec 31, 2021 | -$11.28M | – |
| FY2020 | Dec 31, 2020 | -$6.57M | – |
| FY2019 | Dec 31, 2019 | -$5.78M | – |
| FY2018 | Dec 31, 2018 | -$4.41M | – |
| FY2017 | Dec 31, 2017 | -$1.69M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.48M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.82M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.96M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.77M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.85M | – |
| Q2 FY2025 | Jun 30, 2025 | -$130.02K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.95M | – |
| Q4 FY2024 | Dec 31, 2024 | -$696.40K | – |
| Q3 FY2024 | Sep 30, 2024 | -$201.06K | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.96M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.11M | – |
| Q4 FY2023 | Dec 31, 2023 | -$923.38K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.96M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.65M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.19M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.68M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.78M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.78M | -100.1% |
| Q1 FY2022 | Mar 31, 2022 | -$2.85M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.64M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.33M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.90B | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.91B | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.29M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.38M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.91M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.00M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.40M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.54M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.43M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.41M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.23M | – |
| Q3 FY2018 | Sep 30, 2018 | -$801.34K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.72M | – |
| Q1 FY2018 | Mar 31, 2018 | -$660.76K | – |
See a number that looks wrong?